Bill Summary for H 766 (2015-2016)

Printer-friendly: Click to view

Summary date: 

Apr 16 2015

Bill Information:

View NCGA Bill Details2015-2016 Session
House Bill 766 (Public) Filed Tuesday, April 14, 2015
AN ACT AMENDING THE EXEMPTION FOR USE OR POSSESSION OF HEMP EXTRACT AND PERMITTING THE USE OF HEMP EXTRACT AS AN ALTERNATIVE TREATMENT FOR INTRACTABLE EPILEPSY WITHOUT PARTICIPATING IN A PILOT STUDY AND REPEALING THE EPILEPSY ALTERNATIVE TREATMENT ACT IN 2021.
Intro. by McElraft.

View: All Summaries for BillTracking:

Bill summary

Amends GS 90-94.1(a) to provide that "hemp extract" means an extract from a cannabis plant or a mixture containing cannabis plant material with all of the following characteristics: (1) contains less than five-tenths (was, three-tenths) of one percent of tetrahydrocannabinol by weight; (2) is composed of at least 5% (was, 10%) cannadidiol by weight; and (3) contains no other psychoactive substance.

Amends GS 90-113.100, the North Carolina Epilepsy Alternative Treatment Act. Declares that the purpose of this act is to permit medical professionals to use hemp extract to treat intractable epilepsy (was, permitted medical professionals to conduct evidence-based studies that were limited in scope to explore using hemp extract to treat intractable epilepsy). Deletes provision that declares it to be a finding of the General Assembly that additional study of the use of hemp extract for treating intractable epilepsy is needed.

Amends GS 90-113.101, regarding definitions for terms as they apply in this statute, to remove from the definition of neurologistthe specification that the individual must be affiliated with the neurology department at specific universities licensed in this state. Deletes the definition for pilot study.

Amends GS 90-113.102 and GS 90-113.103 to remove all references to conducting a pilot study of the use of hemp extract to treat intractable epilepsy. Requires a neurologist seeking to use hemp extract as an alternative treatment for intractable epilepsy for one or more patients to submit an application to the Department of Health and Human Services (DHHS) providing the name of the neurologist, the name of the hospital with which the neurologist is affiliated, an explanation of the treatment protocols involved, and any other information that DHHS deems necessary. Requires DHHS to register in the database the neurologists whose applications are approved.

Makes conforming changes to GS 90-113.104 and GS 90-113.105, deleting all references to conducting a pilot study.

Becomes effective December 1, 2015.